Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug testing and analysis

Showing results (811-820 of 2,524) with videos related to

Pageof 253
Sort By:
Drug Testing and Analysis|November 11, 2022
Comments on "discrepancies between validated GC-FID and UHPLC-DAD methods for the analysis of Δ-9-THC and CBD in dried hemp flowers"Kenji Tsujikawa, Yuko T Iwata
Drug Testing and Analysis|September 13, 2021
Metabolite elucidation of 2-fluoro-deschloroketamine (2F-DCK) using molecular networking across three complementary in vitro and in vivo modelsThomas Gicquel, Romain Pelletier, Camille Richeval, et al.
Drug Testing and Analysis|January 20, 2023
The duration of ketamine detection in hair after treatment cessation: Case study and review of the literature in forensic and clinical caseworkI-A Larabi, I Etting, J-C Alvarez
Drug Testing and Analysis|January 21, 2023
Automated identification of unknown doping agents in confiscation samples by flow-injection mass spectrometry and mass spectral library searchesFuyu Guan, Savannah Fay, Matthew A Adreance, et al.
Drug Testing and Analysis|December 23, 2022
New gamma-hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid conjugates in urineAndrea E Steuer, Linda Sutter, Christian Steuer, et al.
Drug Testing and Analysis|January 7, 2023
Urine concentrations of vilanterol and its metabolites, GSK932009 and GW630200, after inhalation of therapeutic and supratherapeutic dosesMartin Østergaard, Søren Jessen, Erik Søren Halvard Hansen, et al.
Drug Testing and Analysis|December 29, 2022
Assay validation for vilanterol and its metabolites in human urine with application for doping control analysisTina Panchal, Sandra Baldwin, Martin Østergaard, et al.
Drug Testing and Analysis|December 30, 2022
Intelligence-based doping control planning improves testing effectiveness: Perspectives from a national anti-doping organisationFredrik Lauritzen, Geir Holden
Drug Testing and Analysis|July 13, 2021
The in vivo metabolism of Furazadrol in greyhoundsAndy Pranata, Blake Curtis, Christopher C Waller, et al.
Drug Testing and Analysis|May 23, 2022
Detection of de-N-glycosylated EPO with SDS-PAGE: A complementary confirmation procedure for recombinant EPO in blood samplesSen He, Xinchao Liu, Die Wu, et al.
Pageof 253

Showing results (811-820 of 2,524) with videos related to

Sort By:
Pageof 253
Drug Testing and Analysis|November 11, 2022
Comments on "discrepancies between validated GC-FID and UHPLC-DAD methods for the analysis of Δ-9-THC and CBD in dried hemp flowers"Kenji Tsujikawa, Yuko T Iwata
Drug Testing and Analysis|September 13, 2021
Metabolite elucidation of 2-fluoro-deschloroketamine (2F-DCK) using molecular networking across three complementary in vitro and in vivo modelsThomas Gicquel, Romain Pelletier, Camille Richeval, et al.
Drug Testing and Analysis|January 20, 2023
The duration of ketamine detection in hair after treatment cessation: Case study and review of the literature in forensic and clinical caseworkI-A Larabi, I Etting, J-C Alvarez
Drug Testing and Analysis|January 21, 2023
Automated identification of unknown doping agents in confiscation samples by flow-injection mass spectrometry and mass spectral library searchesFuyu Guan, Savannah Fay, Matthew A Adreance, et al.
Drug Testing and Analysis|December 23, 2022
New gamma-hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid conjugates in urineAndrea E Steuer, Linda Sutter, Christian Steuer, et al.
Drug Testing and Analysis|January 7, 2023
Urine concentrations of vilanterol and its metabolites, GSK932009 and GW630200, after inhalation of therapeutic and supratherapeutic dosesMartin Østergaard, Søren Jessen, Erik Søren Halvard Hansen, et al.
Drug Testing and Analysis|December 29, 2022
Assay validation for vilanterol and its metabolites in human urine with application for doping control analysisTina Panchal, Sandra Baldwin, Martin Østergaard, et al.
Drug Testing and Analysis|December 30, 2022
Intelligence-based doping control planning improves testing effectiveness: Perspectives from a national anti-doping organisationFredrik Lauritzen, Geir Holden
Drug Testing and Analysis|July 13, 2021
The in vivo metabolism of Furazadrol in greyhoundsAndy Pranata, Blake Curtis, Christopher C Waller, et al.
Drug Testing and Analysis|May 23, 2022
Detection of de-N-glycosylated EPO with SDS-PAGE: A complementary confirmation procedure for recombinant EPO in blood samplesSen He, Xinchao Liu, Die Wu, et al.
Pageof 253